R. Meyer

No ORCID on file · 8 papers in corpus
observational 2026
·doi:10.1097/aog.0000000000006210.18

INTRODUCTION: Endometriosis affects approximately 10% of reproductive-aged individuals and may involve the appendix in up to 30% of cases [1–3]. Appendectomy at the time of surgical management can reveal occult pathology even in normal-appe…

2026
·doi:10.1097/aog.0000000000006204.17

INTRODUCTION: The U.S. Food and Drug Administration (FDA) has approved several pharmacological therapies for endometriosis, based on randomized controlled trial (RCT) data. Although these results have shaped current practice, reliance on th…

other 2026
·doi:10.1097/aog.0000000000006207.7

INTRODUCTION: Surgical management of advanced endometriosis requires effective exposure of the pelvic organs to facilitate a safe and effective excision. Pelvic organ suspension techniques provide the means of optimizing the surgical field …

2025
·doi:10.1016/j.jmig.2025.09.219
2025
·doi:10.1016/j.jmig.2025.09.017
2025
·doi:10.1016/j.jmig.2025.09.011
2025
·doi:10.1097/aog.0000000000005851.234

INTRODUCTION: Bladder endometriosis is the presentation of abnormal endometrial glands and stroma in the detrusor muscle of the bladder. Although generally considered a relatively rare phenomenon affecting only about 1% of women with endome…

2023
·doi:10.1016/j.ajog.2022.12.292